Home > Insider Trading > Filing (0001179110-15-001181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578850	Gregory Neil Almstead	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Evp, Research And Cmc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-20	5,000	$10.85	34,881	No	4	M	Direct
Common Stock	Acquisiton	2015-01-20	20,100	$10.85	54,981	No	4	M	Direct
Common Stock	Disposition	2015-01-20	24,600	$60.25	30,381	No	4	S	Direct
Common Stock	Disposition	2015-01-20	500	$61.02	29,881	No	4	S	Direct
Common Stock	Acquisiton	2015-01-21	996	$10.85	30,877	No	4	M	Direct
Common Stock	Disposition	2015-01-21	996	$60.00	29,881	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right To Buy)	Acquisiton	2015-01-20	5,000	$0.00	5,000	$10.85
Common Stock	Stock Option (Right To Buy)	Acquisiton	2015-01-20	20,100	$0.00	20,100	$10.85
Common Stock	Stock Option (Right To Buy)	Acquisiton	2015-01-21	996	$0.00	996	$10.85

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2023-05-15	No	4	M	Direct
74,900	2023-05-15	No	4	M	Direct
73,904	2023-05-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,374	Indirect	By spouse

Footnotes

The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.00 to $60.98 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $61.00 to $61.06 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.